ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 14 for:    multiple myeloma and galway

A Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care for the Treatment of Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02811822
Recruitment Status : Active, not recruiting
First Posted : June 23, 2016
Last Update Posted : January 10, 2019
Sponsor:
Information provided by (Responsible Party):
GlycoMimetics Incorporated

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : August 2019
  Estimated Study Completion Date : March 2021